1. Liu, Jun, Mi, Jinglin, Liu, Shiqian, Chen, Haiqiang, Jiang, Li. 2022. PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma. In FEBS open bio, 12, 2025-2041. doi:10.1002/2211-5463.13479. https://pubmed.ncbi.nlm.nih.gov/36062301/
2. Lv, Ying, Hu, Qian, Shi, Mingyang, Zhang, Aihua, Hu, Yong. 2020. The role of PSMB5 in sodium arsenite-induced oxidative stress in L-02 cells. In Cell stress & chaperones, 25, 533-540. doi:10.1007/s12192-020-01104-1. https://pubmed.ncbi.nlm.nih.gov/32301004/
3. Wang, Chih-Yang, Li, Chung-Yen, Hsu, Hui-Ping, Chen, Yi-Ling, Lai, Ming-Derg. 2017. PSMB5 plays a dual role in cancer development and immunosuppression. In American journal of cancer research, 7, 2103-2120. doi:. https://pubmed.ncbi.nlm.nih.gov/29218236/
4. Kohda, K, Matsuda, Y, Ishibashi, T, Tanaka, K, Kasahara, M. . Structural analysis and chromosomal localization of the mouse Psmb5 gene coding for the constitutively expressed beta-type proteasome subunit. In Immunogenetics, 47, 77-87. doi:. https://pubmed.ncbi.nlm.nih.gov/9382924/
5. Lai, Guangrui, Sun, Ru, Wu, Jingjing, Zhang, Bijun, Zhao, Yanyan. 2017. 20-HETE regulated PSMB5 expression via TGF-β/Smad signaling pathway. In Prostaglandins & other lipid mediators, 134, 123-130. doi:10.1016/j.prostaglandins.2017.08.005. https://pubmed.ncbi.nlm.nih.gov/28807746/
6. Ramage, Dylan E, Grant, Drew W, Timms, Richard T. 2025. Loss-of-function mutations in the dystonia gene THAP1 impair proteasome function by inhibiting PSMB5 expression. In Nature communications, 16, 1511. doi:10.1038/s41467-025-56782-1. https://pubmed.ncbi.nlm.nih.gov/39929834/
7. Oerlemans, Ruud, Franke, Niels E, Assaraf, Yehuda G, Scheper, Rik J, Jansen, Gerrit. 2008. Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. In Blood, 112, 2489-99. doi:10.1182/blood-2007-08-104950. https://pubmed.ncbi.nlm.nih.gov/18565852/
智鼠故事 
